{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:26:03Z","timestamp":1774110363274,"version":"3.50.1"},"reference-count":304,"publisher":"Elsevier","isbn-type":[{"value":"9780128047996","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.ai.2015.09.004","type":"book-chapter","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T05:11:14Z","timestamp":1445836274000},"page":"55-107","source":"Crossref","is-referenced-by-count":7,"title":["Evolution of the Humoral Response during HCV Infection"],"prefix":"10.1016","author":[{"given":"Armstrong","family":"Murira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Lamarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0005","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/JVI.79.5.2823-2830.2005","article-title":"Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection","volume":"79","author":"Aasa-Chapman","year":"2005","journal-title":"Journal of Virology"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/jvh.12173","article-title":"The new paradigm of hepatitis C therapy: Integration of oral therapies into best practices","volume":"20","author":"Afdhal","year":"2013","journal-title":"Journal of Viral Hepatitis"},{"issue":"22","key":"10.1016\/bs.ai.2015.09.004_bb0015","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0020","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.4049\/jimmunol.178.7.4424","article-title":"The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes","volume":"178","author":"Alam","year":"2007","journal-title":"Journal of Immunology"},{"issue":"48","key":"10.1016\/bs.ai.2015.09.004_bb0025","doi-asserted-by":"crossref","first-page":"20234","DOI":"10.1073\/pnas.0908713106","article-title":"Role of HIV membrane in neutralization by two broadly neutralizing antibodies","volume":"106","author":"Alam","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/bs.ai.2015.09.004_bb0030","doi-asserted-by":"crossref","first-page":"e85098","DOI":"10.1371\/journal.pone.0085098","article-title":"9G4+ antibodies isolated from HIV-infected patients neutralize HIV-1 and have distinct autoreactivity profiles","volume":"8","author":"Alcena","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 10","key":"10.1016\/bs.ai.2015.09.004_bb0035","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1099\/0022-1317-81-10-2451","article-title":"Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81","volume":"81","author":"Allander","year":"2000","journal-title":"The Journal of General Virology"},{"issue":"Suppl 2","key":"10.1016\/bs.ai.2015.09.004_bb0040","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1086\/655654","article-title":"The humoral response to HIV-1: New insights, renewed focus","volume":"202","author":"Alter","year":"2010","journal-title":"Journal of Infectious Diseases"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0045","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/JVI.00313-11","article-title":"Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses","volume":"85","author":"Asmal","year":"2011","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.chembiol.2010.03.012","article-title":"Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds","volume":"17","author":"Astronomo","year":"2010","journal-title":"Chemistry and Biology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0055","first-page":"234","article-title":"Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome","volume":"63","author":"Aucouturier","year":"1986","journal-title":"Clinical and Experimental Immunology"},{"issue":"Suppl 1","key":"10.1016\/bs.ai.2015.09.004_bb0060","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cis361","article-title":"Global burden of hepatitis C: Considerations for healthcare providers in the United States","volume":"55","author":"Averhoff","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"7379","key":"10.1016\/bs.ai.2015.09.004_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature10660","article-title":"Antibody-based protection against HIV infection by vectored immunoprophylaxis","volume":"481","author":"Balazs","year":"2012","journal-title":"Nature"},{"issue":"115","key":"10.1016\/bs.ai.2015.09.004_bb0070","doi-asserted-by":"crossref","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0075","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nature Reviews. Microbiology"},{"issue":"42","key":"10.1016\/bs.ai.2015.09.004_bb0080","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"Barth","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"24","key":"10.1016\/bs.ai.2015.09.004_bb0085","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1073\/pnas.2335981100","article-title":"In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes","volume":"100","author":"Bartosch","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0095","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.157.5.2168","article-title":"HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression","volume":"157","author":"Baum","year":"1996","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2901","article-title":"The double life of a B-1 cell: Self-reactivity selects for protective effector functions","volume":"11","author":"Baumgarth","year":"2011","journal-title":"Nature Reviews. Immunology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0105","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1073\/pnas.96.5.2250","article-title":"Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system","volume":"96","author":"Baumgarth","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5128","key":"10.1016\/bs.ai.2015.09.004_bb0110","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1126\/science.7690497","article-title":"Immunoglobulin VH3 gene products: Natural ligands for HIV gp120","volume":"261","author":"Berberian","year":"1993","journal-title":"Science"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0115","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1182\/blood-2011-04-345579","article-title":"Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways","volume":"118","author":"Berkowska","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb0120","first-page":"2114","article-title":"VH4-34 encoded antibody in systemic lupus erythematosus: Effect of isotype","volume":"29","author":"Bhat","year":"2002","journal-title":"Journal of Rheumatology"},{"issue":"24","key":"10.1016\/bs.ai.2015.09.004_bb0125","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin","volume":"331","author":"Bjoro","year":"1994","journal-title":"The New England Journal of Medicine"},{"issue":"19","key":"10.1016\/bs.ai.2015.09.004_bb9010","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.05045-11","article-title":"Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors","volume":"85","author":"Bonsignori","year":"2011","journal-title":"Journal of Virology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0130","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/JVI.07163-11","article-title":"Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: Implications for vaccine design","volume":"86","author":"Bonsignori","year":"2012","journal-title":"Journal of Virology"},{"issue":"21","key":"10.1016\/bs.ai.2015.09.004_bb0135","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"Bonsignori","year":"2012","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm0297-205","article-title":"Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus","volume":"3","author":"Borrow","year":"1997","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0145","doi-asserted-by":"crossref","first-page":"e16857","DOI":"10.1371\/journal.pone.0016857","article-title":"Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease","volume":"6","author":"Breden","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"Brimacombe","year":"2011","journal-title":"Journal of Virology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0160","doi-asserted-by":"crossref","first-page":"e36750","DOI":"10.1371\/journal.pone.0036750","article-title":"Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes","volume":"7","author":"Briney","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2567.2012.03605.x","article-title":"Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire","volume":"137","author":"Briney","year":"2012","journal-title":"Immunology"},{"issue":"23","key":"10.1016\/bs.ai.2015.09.004_bb0170","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"Journal of Virology"},{"issue":"5187","key":"10.1016\/bs.ai.2015.09.004_bb9015","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0175","doi-asserted-by":"crossref","first-page":"e5427","DOI":"10.1371\/journal.pone.0005427","article-title":"CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection","volume":"4","author":"Cagigi","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb9020","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/hep.27278","article-title":"T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee","volume":"60","author":"Callendret","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"28","key":"10.1016\/bs.ai.2015.09.004_bb0180","first-page":"9261","article-title":"Cytokinome profile evaluation in patients with hepatitis C virus infection","volume":"20","author":"Capone","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0185","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1172\/JCI24179","article-title":"Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus","volume":"115","author":"Cappione","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb0190","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.174.10.6532","article-title":"Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: A model of infection-driven lymphomagenesis","volume":"174","author":"Carbonari","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.1016\/bs.ai.2015.09.004_bb9025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-med-062909-130018","article-title":"Immunogenetics of spontaneous control of HIV","volume":"63","author":"Carrington","year":"2012","journal-title":"Annual Review of Medicine"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb0195","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1086\/508198","article-title":"Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment","volume":"43","author":"Castillo","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"20","key":"10.1016\/bs.ai.2015.09.004_bb0200","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1182\/blood-2010-10-312942","article-title":"Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset","volume":"117","author":"Charles","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0205","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2007-07-101717","article-title":"Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia","volume":"111","author":"Charles","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","article-title":"Limited humoral immunity in hepatitis C virus infection","volume":"116","author":"Chen","year":"1999","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0215","doi-asserted-by":"crossref","first-page":"e80078","DOI":"10.1371\/journal.pone.0080078","article-title":"Persistence of hepatitis C virus during and after otherwise clinically successful treatment of chronic hepatitis C with standard pegylated interferon alpha-2b and ribavirin therapy","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"4902","key":"10.1016\/bs.ai.2015.09.004_bb0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2040622314551934","article-title":"Beyond interferon: Rationale and prospects for newer treatment paradigms for chronic hepatitis C","volume":"6","author":"Cortez","year":"2015","journal-title":"Therapeutic Advances in Chronic Disease"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0235","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1006\/jaut.1994.1043","article-title":"Involvement of CD4+ cells in lymphocytic choriomeningitis virus-induced autoimmune anaemia and hypergammaglobulinaemia","volume":"7","author":"Coutelier","year":"1994","journal-title":"Journal of Autoimmunity"},{"issue":"26","key":"10.1016\/bs.ai.2015.09.004_bb0240","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1182\/blood-2012-12-471953","article-title":"Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype","volume":"121","author":"Covens","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0245","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.20749","article-title":"Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C","volume":"42","author":"Cox","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10875-006-9051-1","article-title":"Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss","volume":"27","author":"Culton","year":"2007","journal-title":"Journal of Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0255","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4049\/jimmunol.176.2.790","article-title":"Early preplasma cells define a tolerance checkpoint for autoreactive B cells","volume":"176","author":"Culton","year":"2006","journal-title":"Journal of Immunology"},{"issue":"7109","key":"10.1016\/bs.ai.2015.09.004_bb9030","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0260","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood-2003-07-2375","article-title":"Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection","volume":"103","author":"De Milito","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb0265","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","article-title":"Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia","volume":"96","author":"De Re","year":"2000","journal-title":"Blood"},{"key":"10.1016\/bs.ai.2015.09.004_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2003.tb06036.x","article-title":"Mechanisms of autoantibody diversification to SLE-related autoantigens","volume":"987","author":"Deshmukh","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0275","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3390\/v3112280","article-title":"Hepatitis C virus evasion mechanisms from neutralizing antibodies","volume":"3","author":"Di Lorenzo","year":"2011","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0280","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2013.12.001","article-title":"Peripheral CD27-CD21-B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis","volume":"150","author":"Doi","year":"2014","journal-title":"Clinical Immunology"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0285","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/JVI.02820-12","article-title":"2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies","volume":"87","author":"Doores","year":"2013","journal-title":"Journal of Virology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0290","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/COH.0b013e32832d9fac","article-title":"Antibody-secreting B cells in HIV infection","volume":"4","author":"Doria-Rose","year":"2009","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0295","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JVI.01482-09","article-title":"Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables","volume":"84","author":"Doria-Rose","year":"2010","journal-title":"Journal of Virology"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0300","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0305","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.1301285","article-title":"Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10","volume":"191","author":"Doyle-Cooper","year":"2013","journal-title":"Journal of Immunology"},{"issue":"7137","key":"10.1016\/bs.ai.2015.09.004_bb0310","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.smim.2007.12.002","article-title":"Plasma cell development: From B-cell subsets to long-term survival niches","volume":"20","author":"Fairfax","year":"2008","journal-title":"Seminars in Immunology"},{"issue":"15","key":"10.1016\/bs.ai.2015.09.004_bb0320","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1128\/JVI.00459-07","article-title":"Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization","volume":"81","author":"Falkowska","year":"2007","journal-title":"Journal of Virology"},{"issue":"16","key":"10.1016\/bs.ai.2015.09.004_bb0325","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1073\/pnas.91.16.7792","article-title":"Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization","volume":"91","author":"Farci","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0330","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM199107113250205","article-title":"A long-term study of hepatitis C virus replication in non-A, non-B hepatitis","volume":"325","author":"Farci","year":"1991","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0335","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.coi.2007.04.003","article-title":"Local development of effector and memory T helper cells","volume":"19","author":"Fazilleau","year":"2007","journal-title":"Current Opinion in Immunology"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb9035","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00535-012-0568-1","article-title":"Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5(+) T follicular helper cells","volume":"47","author":"Feng","year":"2012","journal-title":"Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0340","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","article-title":"Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer","volume":"7","author":"Ferri","year":"2015","journal-title":"World Journal of Hepatology"},{"issue":"13","key":"10.1016\/bs.ai.2015.09.004_bb0345","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0350","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/JVI.79.4.2042-2049.2005","article-title":"Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1","volume":"79","author":"Forthal","year":"2005","journal-title":"Journal of Virology"},{"issue":"38","key":"10.1016\/bs.ai.2015.09.004_bb0355","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"Frey","year":"2010","journal-title":"Vaccine"},{"issue":"8722","key":"10.1016\/bs.ai.2015.09.004_bb0360","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0140-6736(90)92487-3","article-title":"Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates","volume":"336","author":"Garson","year":"1990","journal-title":"Lancet"},{"issue":"30","key":"10.1016\/bs.ai.2015.09.004_bb0365","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.2174\/09298673113209990178","article-title":"A novel promising therapeutic option against hepatitis C virus: An oral nucleotide NS5B polymerase inhibitor sofosbuvir","volume":"20","author":"Gentile","year":"2013","journal-title":"Current Medicinal Chemistry"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0370","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4049\/jimmunol.1302515","article-title":"Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline","volume":"192","author":"Georgiev","year":"2014","journal-title":"Journal of Immunology"},{"issue":"16","key":"10.1016\/bs.ai.2015.09.004_bb0375","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0380","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/jiq152","article-title":"Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: A case study for statistical issues in efficacy trials","volume":"203","author":"Gilbert","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"13","key":"10.1016\/bs.ai.2015.09.004_bb0385","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins","volume":"79","author":"Goffard","year":"2005","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0390","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.4049\/jimmunol.174.4.2185","article-title":"Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251","volume":"174","author":"Gomez-Roman","year":"2005","journal-title":"Journal of Immunology"},{"issue":"19","key":"10.1016\/bs.ai.2015.09.004_bb0395","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1128\/JVI.01414-12","article-title":"A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection","volume":"86","author":"Goo","year":"2012","journal-title":"Journal of Virology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0400","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"Journal of Experimental Medicine"},{"issue":"5645","key":"10.1016\/bs.ai.2015.09.004_bb0405","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"issue":"15","key":"10.1016\/bs.ai.2015.09.004_bb0410","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1128\/JVI.00563-11","article-title":"Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual","volume":"85","author":"Gray","year":"2011","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.20101499","article-title":"Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70","volume":"208","author":"Griffin","year":"2011","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0420","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1084\/jem.20120403","article-title":"Human CD11b+ B1 cells are not monocytes: A reply to \u201cGene profiling of CD11b+ and CD11b\u2212 B1 cell subsets reveals potential cell sorting artifacts\u201d","volume":"209","author":"Griffin","year":"2012","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/bs.ai.2015.09.004_bb0425","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.immunol.17.1.625","article-title":"Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues","volume":"17","author":"Haase","year":"1999","journal-title":"Annual Review of Immunology"},{"issue":"22","key":"10.1016\/bs.ai.2015.09.004_bb0430","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.74.22.10407-10416.2000","article-title":"Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes","volume":"74","author":"Hadlock","year":"2000","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.ai.2015.09.004_bb0435","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","article-title":"B cell development pathways","volume":"19","author":"Hardy","year":"2001","journal-title":"Annual Review of Immunology"},{"issue":"5730","key":"10.1016\/bs.ai.2015.09.004_bb0440","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/science.1111781","article-title":"Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies","volume":"308","author":"Haynes","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0445","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.176.7.3931","article-title":"HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors","volume":"176","author":"He","year":"2006","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0450","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/hep.22484","article-title":"Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection","volume":"48","author":"Hoare","year":"2008","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"10.1016\/bs.ai.2015.09.004_bb0455","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/bs.ai.2015.09.004_bb0460","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7424","key":"10.1016\/bs.ai.2015.09.004_bb9040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0465","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni911","article-title":"Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections","volume":"4","author":"Hunziker","year":"2003","journal-title":"Nature Immunology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0470","doi-asserted-by":"crossref","first-page":"e90725","DOI":"10.1371\/journal.pone.0090725","article-title":"IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria","volume":"9","author":"Hwang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0475","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1172\/JCI111959","article-title":"Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients","volume":"76","author":"Isenberg","year":"1985","journal-title":"The Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0480","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"issue":"41","key":"10.1016\/bs.ai.2015.09.004_bb0485","doi-asserted-by":"crossref","first-page":"16269","DOI":"10.1073\/pnas.0705522104","article-title":"Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus","volume":"104","author":"Johansson","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0490","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.1967","article-title":"Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys","volume":"15","author":"Johnson","year":"2009","journal-title":"Nature Medicine"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb0495","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMp1107621","article-title":"HIV vaccine development\u2014Improving on natural immunity","volume":"365","author":"Johnston","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0500","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1172\/JCI45685","article-title":"Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors","volume":"121","author":"Kardava","year":"2011","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0505","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.94.4.1356","article-title":"Identification of the B cell superantigen-binding site of HIV-1 gp120","volume":"94","author":"Karray","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0510","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1128\/JVI.67.7.3923-3930.1993","article-title":"Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus","volume":"67","author":"Kato","year":"1993","journal-title":"Journal of Virology"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb0515","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri888","article-title":"Viruses and interferon: A fight for supremacy","volume":"2","author":"Katze","year":"2002","journal-title":"Nature Reviews. Immunology"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0520","doi-asserted-by":"crossref","first-page":"e1002653","DOI":"10.1371\/journal.ppat.1002653","article-title":"Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate","volume":"8","author":"Keck","year":"2012","journal-title":"PLoS Pathogens"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0525","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.4049\/jimmunol.164.8.4111","article-title":"Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors","volume":"164","author":"Kenny","year":"2000","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0530","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/smim.1994.1045","article-title":"Antibody structure and the evolution of immunoglobulin V gene segments","volume":"6","author":"Kirkham","year":"1994","journal-title":"Seminars in Immunology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0535","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1084\/jem.20120423","article-title":"Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein","volume":"209","author":"Klein","year":"2012","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0540","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1478-3231.2006.01406.x","article-title":"Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: A multicenter, retrospective cohort study of 1124 patients","volume":"27","author":"Kobayashi","year":"2007","journal-title":"Liver International"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0545","doi-asserted-by":"crossref","first-page":"e35356","DOI":"10.1371\/journal.pone.0035356","article-title":"9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity","volume":"7","author":"Kobie","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0550","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1172\/JCI27628","article-title":"Mature B cells class switched to IgD are autoreactive in healthy individuals","volume":"117","author":"Koelsch","year":"2007","journal-title":"Journal of Clinical Investigation"},{"issue":"44","key":"10.1016\/bs.ai.2015.09.004_bb0555","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.3748\/wjg.v19.i44.7889","article-title":"Direct effects of hepatitis C virus on the lymphoid cells","volume":"19","author":"Kondo","year":"2013","journal-title":"World Journal of Gastroenterology"},{"issue":"6162","key":"10.1016\/bs.ai.2015.09.004_bb0560","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0565","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/JVI.79.2.780-790.2005","article-title":"Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking","volume":"79","author":"Krachmarov","year":"2005","journal-title":"Journal of Virology"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0570","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20022020","article-title":"Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen","volume":"197","author":"Kruetzmann","year":"2003","journal-title":"Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0575","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.1840180602","article-title":"Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection","volume":"18","author":"Kurosaki","year":"1993","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0580","doi-asserted-by":"crossref","first-page":"a007278","DOI":"10.1101\/cshperspect.a007278","article-title":"Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1","volume":"1","author":"Kwong","year":"2011","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0585","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1128\/JVI.72.5.3539-3546.1998","article-title":"Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus","volume":"72","author":"Lagging","year":"1998","journal-title":"Journal of Virology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0590","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome","volume":"309","author":"Lane","year":"1983","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0595","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/mt.2011.188","article-title":"Hepatitis C virus NS3\/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected]","volume":"20","author":"Lang Kuhs","year":"2012","journal-title":"Molecular Therapy"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb9100","doi-asserted-by":"crossref","first-page":"e26981","DOI":"10.1371\/journal.pone.0026981","article-title":"Structural basis for broad neutralization of hepatitis C virus quasispecies","volume":"6","author":"Lapierre","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb0600","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0605","doi-asserted-by":"crossref","first-page":"e59776","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0610","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nature Medicine"},{"issue":"41","key":"10.1016\/bs.ai.2015.09.004_bb0615","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.vaccine.2013.07.030","article-title":"Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19(+)CD20(+)CD3(-)CD70(-)CD27(+)IgM(+)CD43(+)CD5(+)\/(-)","volume":"31","author":"Leggat","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0620","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.4049\/jimmunol.162.11.6384","article-title":"Cellular basis of B cell clonal populations in old mice","volume":"162","author":"LeMaoult","year":"1999","journal-title":"The Journal of Immunology"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0625","doi-asserted-by":"crossref","first-page":"e1000107","DOI":"10.1371\/journal.pmed.1000107","article-title":"Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection","volume":"6","author":"Levesque","year":"2009","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0630","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.coviro.2011.11.001","article-title":"Induction and function of type I and III interferon in response to viral infection","volume":"1","author":"Levy","year":"2011","journal-title":"Current Opinion in Virology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0635","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00281-012-0332-x","article-title":"Innate immune responses in hepatitis C virus infection","volume":"35","author":"Li","year":"2013","journal-title":"Seminars in Immunopathology"},{"issue":"7037","key":"10.1016\/bs.ai.2015.09.004_bb9045","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nature03513","article-title":"Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells","volume":"434","author":"Li","year":"2005","journal-title":"Nature"},{"issue":"7446","key":"10.1016\/bs.ai.2015.09.004_bb0640","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"issue":"5734","key":"10.1016\/bs.ai.2015.09.004_bb0645","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb9050","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1172\/JCI64314","article-title":"Expansion of HIV-specific T follicular helper cells in chronic HIV infection","volume":"122","author":"Lindqvist","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0650","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.190.1.75","article-title":"B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals","volume":"190","author":"Loder","year":"1999","journal-title":"Journal of Experimental Medicine"},{"issue":"27","key":"10.1016\/bs.ai.2015.09.004_bb0655","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ai.2015.09.004_bb0660","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.0105-2896.2004.0112.x","article-title":"Development and selection of marginal zone B cells","volume":"197","author":"Lopes-Carvalho","year":"2004","journal-title":"Immunological Reviews"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0665","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/157016210794088290","article-title":"Polyvalent AIDS vaccines","volume":"8","author":"Lu","year":"2010","journal-title":"Current HIV Research"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0670","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20040358","article-title":"Molecular characterization of virus-induced autoantibody responses","volume":"200","author":"Ludewig","year":"2004","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0675","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0680","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2007.03.008","article-title":"Duration, combination and timing: The signal integration model of dendritic cell activation","volume":"28","author":"Macagno","year":"2007","journal-title":"Trends in Immunology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0685","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0690","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/cncr.20537","article-title":"Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy","volume":"101","author":"Makiyama","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0695","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/jid.2008.240","article-title":"B cells and immunological tolerance","volume":"129","author":"Manjarrez-Orduno","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0700","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","article-title":"Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma","volume":"159","author":"Marasca","year":"2001","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb9105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: A case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0705","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1371\/journal.pbio.0000016","article-title":"V(D)J recombination and the evolution of the adaptive immune system","volume":"1","author":"Market","year":"2003","journal-title":"PLoS Biology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0710","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00001622-200209000-00009","article-title":"B-cell activation and lymphoma in patients with HIV","volume":"14","author":"Martinez-Maza","year":"2002","journal-title":"Current Opinion in Oncology"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0715","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.4049\/jimmunol.138.11.3720","article-title":"Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity","volume":"138","author":"Martinez-Maza","year":"1987","journal-title":"Journal of Immunology"},{"issue":"7037","key":"10.1016\/bs.ai.2015.09.004_bb0720","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection","volume":"434","author":"Mattapallil","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0725","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2003","journal-title":"The American Journal of the Medical Sciences"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0730","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/JVI.78.7.3279-3295.2004","article-title":"N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies","volume":"78","author":"McCaffrey","year":"2004","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0735","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1568005054201580","article-title":"Antibodies: Can they protect against HIV infection?","volume":"5","author":"Mc Cann","year":"2005","journal-title":"Current Drug Targets. Infectious Disorders"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0740","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0952-7915(03)00046-3","article-title":"B cells as effectors","volume":"15","author":"McHeyzer-Williams","year":"2003","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/bs.ai.2015.09.004_bb0745","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.immunol.23.021704.115732","article-title":"Antigen-specific memory B cell development","volume":"23","author":"McHeyzer-Williams","year":"2005","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/bs.ai.2015.09.004_bb0750","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.immunol.24.021605.090605","article-title":"HIV vaccines","volume":"24","author":"McMichael","year":"2006","journal-title":"Annual Review of Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0755","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: Clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nature Reviews. Immunology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0760","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI13051","article-title":"Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development","volume":"108","author":"Meffre","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0765","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.22547","article-title":"Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo","volume":"48","author":"Meuleman","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0770","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JVI.01872-07","article-title":"Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0775","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"Journal of Viral Hepatitis"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0780","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.ppat.1001251","article-title":"Characteristics of the earliest cross-neutralizing antibody response to HIV-1","volume":"7","author":"Mikell","year":"2011","journal-title":"PLoS Pathogens"},{"issue":"6139","key":"10.1016\/bs.ai.2015.09.004_bb0785","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/329547a0","article-title":"Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site","volume":"329","author":"Milich","year":"1987","journal-title":"Nature"},{"issue":"33","key":"10.1016\/bs.ai.2015.09.004_bb0790","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1073\/pnas.1008877107","article-title":"Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt","volume":"107","author":"Miller","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0795","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/bs.ai.2015.09.004_bb0800","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","article-title":"Pathogenic mechanisms of HIV disease","volume":"6","author":"Moir","year":"2011","journal-title":"Annual Review of Pathology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0805","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0810","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.192.5.637","article-title":"B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells","volume":"192","author":"Moir","year":"2000","journal-title":"Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0815","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/JVI.06349-11","article-title":"Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane","volume":"86","author":"Montero","year":"2012","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0820","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/JVI.02187-07","article-title":"The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection","volume":"82","author":"Moore","year":"2008","journal-title":"Journal of Virology"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0825","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1128\/JVI.02658-10","article-title":"Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop","volume":"85","author":"Moore","year":"2011","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0830","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0835","doi-asserted-by":"crossref","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathogens"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb0840","doi-asserted-by":"crossref","first-page":"e23532","DOI":"10.1371\/journal.pone.0023532","article-title":"Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting","volume":"6","author":"Morris","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0845","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0145-2126(00)00107-7","article-title":"Cells of the marginal zone\u2014Origins, function and neoplasia","volume":"25","author":"Morse","year":"2001","journal-title":"Leukemia Research"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0850","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.coi.2006.03.004","article-title":"Stromal niches, plasma cell differentiation and survival","volume":"18","author":"Moser","year":"2006","journal-title":"Current Opinion in Immunology"},{"issue":"7315","key":"10.1016\/bs.ai.2015.09.004_bb0855","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature09385","article-title":"Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation","volume":"467","author":"Mouquet","year":"2010","journal-title":"Nature"},{"issue":"6373","key":"10.1016\/bs.ai.2015.09.004_bb0860","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/357077a0","article-title":"Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice","volume":"357","author":"Murakami","year":"1992","journal-title":"Nature"},{"key":"10.1016\/bs.ai.2015.09.004_bb9110","unstructured":"Murira, A., Henry, K. A., Ahmed, F. K., Klaric, K., Droumeva, R., Kardava, L., et al. (2016). Comparison of humoral immune responses between chronic HIV infection and SLE reveals similar perturbations in B-cell subset distributions and distinct serological profiles. Manuscript in preparation."},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb9055","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1128\/JVI.67.11.6642-6647.1993","article-title":"A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1","volume":"67","author":"Muster","year":"1993","journal-title":"Journal of Virology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0865","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1155\/2014\/317623","article-title":"Burden of disease and cost of chronic hepatitis C infection in Canada","volume":"28","author":"Myers","year":"2014","journal-title":"Canadian Journal of Gastroenterology & Hepatology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0870","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis C virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"5386","key":"10.1016\/bs.ai.2015.09.004_bb0875","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0880","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000329807","article-title":"Success and failure of virus-specific T cell responses in hepatitis C virus infection","volume":"29","author":"Neumann-Haefelin","year":"2011","journal-title":"Digestive Diseases"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0885","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.coi.2006.02.005","article-title":"B cell migration and interactions in the early phase of antibody responses","volume":"18","author":"Okada","year":"2006","journal-title":"Current Opinion in Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0890","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-065X.2010.00940.x","article-title":"Plasma cell development and survival","volume":"237","author":"Oracki","year":"2010","journal-title":"Immunological Reviews"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0895","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jhep.2001.22112","article-title":"Acute hepatitis C","volume":"33","author":"Orland","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0900","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb0905","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/bs.ai.2015.09.004_bb0910","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"Journal of Virology"},{"issue":"Pt 3","key":"10.1016\/bs.ai.2015.09.004_bb0915","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/vir.0.83386-0","article-title":"Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein","volume":"89","author":"Owsianka","year":"2008","journal-title":"The Journal of General Virology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0920","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"The Journal of Infectious Diseases"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0925","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2007.02.011","article-title":"The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles","volume":"26","author":"Pape","year":"2007","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb0930","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","article-title":"Immune responses to HCV and other hepatitis viruses","volume":"40","author":"Park","year":"2014","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb0935","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.20060087","article-title":"Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation","volume":"203","author":"Paus","year":"2006","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0940","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/JVI.01986-07","article-title":"Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein","volume":"82","author":"Perotti","year":"2008","journal-title":"Journal of Virology"},{"issue":"14","key":"10.1016\/bs.ai.2015.09.004_bb0945","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb0950","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2893.2011.01442.x","article-title":"Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus","volume":"19","author":"Pham","year":"2012","journal-title":"Journal of Viral Hepatitis"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb0955","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.4049\/jimmunol.174.8.4567","article-title":"Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen","volume":"174","author":"Phan","year":"2005","journal-title":"Journal of Immunology"},{"issue":"19","key":"10.1016\/bs.ai.2015.09.004_bb0960","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5390","key":"10.1016\/bs.ai.2015.09.004_bb0965","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb0970","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nature Reviews. Immunology"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb0975","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.78.10.5205-5215.2004","article-title":"The V1\/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection","volume":"78","author":"Pinter","year":"2004","journal-title":"Journal of Virology"},{"issue":"7231","key":"10.1016\/bs.ai.2015.09.004_bb0980","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb0985","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2230.2001.00852.x","article-title":"Epitope spreading: Protection from pathogens, but propagation of autoimmunity?","volume":"26","author":"Powell","year":"2001","journal-title":"Clinical and Experimental Dermatology"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb0990","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI200112462","article-title":"Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance","volume":"108","author":"Pugh-Bernard","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb0995","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ni1302","article-title":"Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells","volume":"7","author":"Qiao","year":"2006","journal-title":"Nature Immunology"},{"issue":"13","key":"10.1016\/bs.ai.2015.09.004_bb1000","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","article-title":"The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis","volume":"98","author":"Quinn","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb1005","doi-asserted-by":"crossref","first-page":"e25606","DOI":"10.1371\/journal.pone.0025606","article-title":"Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections","volume":"6","author":"Racanelli","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb1010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1471-4906(03)00178-9","article-title":"Hepatitis C virus infection: When silence is deception","volume":"24","author":"Racanelli","year":"2003","journal-title":"Trends in Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb1015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.20518","article-title":"Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"41","author":"Radkowski","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb1020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/infdis\/jir835","article-title":"Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion","volume":"205","author":"Raghuraman","year":"2012","journal-title":"The Journal of Infectious Diseases"},{"issue":"Pt 1","key":"10.1016\/bs.ai.2015.09.004_bb1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"Randall","year":"2008","journal-title":"The Journal of General Virology"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb9060","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb1030","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/hep.26218","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States","volume":"57","author":"Razavi","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb1035","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nature Reviews. Immunology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb1045","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm0698-679","article-title":"A role for carbohydrates in immune evasion in AIDS","volume":"4","author":"Reitter","year":"1998","journal-title":"Nature Medicine"},{"issue":"23","key":"10.1016\/bs.ai.2015.09.004_bb1050","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb1055","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb1060","first-page":"7","article-title":"IgD production and other lymphocyte functions in HIV infection: Immaturity and activation of B cells at different clinical stages","volume":"75","author":"Rogers","year":"1989","journal-title":"Clinical and Experimental Immunology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1065","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.01839-06","article-title":"Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection","volume":"81","author":"Rong","year":"2007","journal-title":"Journal of Virology"},{"issue":"51","key":"10.1016\/bs.ai.2015.09.004_bb1070","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb1075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ai.2015.09.004_bb1080","doi-asserted-by":"crossref","first-page":"467869","DOI":"10.1155\/2013\/467869","article-title":"Hepatitis C virus NS3 inhibitors: Current and future perspectives","volume":"2013","author":"Salam","year":"2013","journal-title":"BioMed Research International"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb1085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/JVI.02036-08","article-title":"Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection","volume":"83","author":"Sather","year":"2009","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/COH.0000000000000054","article-title":"Immunogen design to focus the B-cell repertoire","volume":"9","author":"Sattentau","year":"2014","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"19","key":"10.1016\/bs.ai.2015.09.004_bb1095","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"The EMBO Journal"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb1100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jim.2008.11.012","article-title":"A method for identification of HIV gp140 binding memory B cells in human blood","volume":"343","author":"Scheid","year":"2009","journal-title":"Journal of Immunological Methods"},{"issue":"44","key":"10.1016\/bs.ai.2015.09.004_bb1105","doi-asserted-by":"crossref","first-page":"18044","DOI":"10.1073\/pnas.1113395108","article-title":"Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells","volume":"108","author":"Scheid","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6049","key":"10.1016\/bs.ai.2015.09.004_bb9065","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"issue":"16","key":"10.1016\/bs.ai.2015.09.004_bb1110","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/QAD.0b013e3282a4a632","article-title":"Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity","volume":"21","author":"Scherer","year":"2007","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb1115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2008.01006.x","article-title":"Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C","volume":"15","author":"Scherzer","year":"2008","journal-title":"Journal of Viral Hepatitis"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb1120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2013.06.024","article-title":"Direct-acting antiviral agents and the path to interferon independence","volume":"12","author":"Schmidt","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb1125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/hep.20906","article-title":"Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity","volume":"42","author":"Schofield","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb1130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"The Lancet Infectious Diseases"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1135","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/JVI.68.3.1494-1500.1994","article-title":"Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses","volume":"68","author":"Shimizu","year":"1994","journal-title":"Journal of Virology"},{"issue":"12","key":"10.1016\/bs.ai.2015.09.004_bb1140","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"issue":"14","key":"10.1016\/bs.ai.2015.09.004_bb1145","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1128\/JVI.00110-09","article-title":"Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm","volume":"83","author":"Simek","year":"2009","journal-title":"Journal of Virology"},{"issue":"Pt 11","key":"10.1016\/bs.ai.2015.09.004_bb1150","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","article-title":"Genetic diversity and evolution of hepatitis C virus\u201415 years on","volume":"85","author":"Simmonds","year":"2004","journal-title":"The Journal of General Virology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrmicro772","article-title":"HIV-1 dynamics in vivo: Implications for therapy","volume":"1","author":"Simon","year":"2003","journal-title":"Nature Reviews. Microbiology"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb1160","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/QAD.0b013e32834785cf","article-title":"Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies","volume":"25","author":"Singh","year":"2011","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb1165","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni1490","article-title":"Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes","volume":"8","author":"Skokos","year":"2007","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb1170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/bs.ai.2015.09.004_bb1175","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.20031498","article-title":"Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen","volume":"198","author":"Song","year":"2003","journal-title":"Journal of Experimental Medicine"},{"issue":"11","key":"10.1016\/bs.ai.2015.09.004_bb1180","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.4049\/jimmunol.172.11.6790","article-title":"Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER","volume":"172","author":"Souto-Carneiro","year":"2004","journal-title":"Journal of Immunology"},{"issue":"19","key":"10.1016\/bs.ai.2015.09.004_bb1185","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1073\/pnas.85.19.7312","article-title":"Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals","volume":"85","author":"Stall","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb1190","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm.1949","article-title":"Neutralizing antibodies generated during natural HIV-1 infection: Good news for an HIV-1 vaccine?","volume":"15","author":"Stamatatos","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ai.2015.09.004_bb1195","first-page":"17","article-title":"Cell culture systems for hepatitis C virus","volume":"369","author":"Steinmann","year":"2013","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"18","key":"10.1016\/bs.ai.2015.09.004_bb9070","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/08892220152741450","article-title":"A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1","volume":"17","author":"Stiegler","year":"2001","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb9075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/cei.12158","article-title":"Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C","volume":"174","author":"Sumida","year":"2013","journal-title":"Clinical and Experimental Immunology"},{"issue":"14","key":"10.1016\/bs.ai.2015.09.004_bb1200","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1128\/JVI.00326-11","article-title":"Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys","volume":"85","author":"Sun","year":"2011","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cld.2008.03.003","article-title":"Hepatitis C and innate immunity: Recent advances","volume":"12","author":"Szabo","year":"2008","journal-title":"Clinics in Liver Disease"},{"issue":"26","key":"10.1016\/bs.ai.2015.09.004_bb1210","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1182\/blood-2013-05-500074","article-title":"To B1 or not to B1: That really is still the question!","volume":"121","author":"Tangye","year":"2013","journal-title":"Blood"},{"key":"10.1016\/bs.ai.2015.09.004_bb1215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-59745-393-6_13","article-title":"Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins","volume":"379","author":"Tarr","year":"2007","journal-title":"Methods in Molecular Biology"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb1220","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb1225","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.3184","article-title":"Global control of hepatitis C: Where challenge meets opportunity","volume":"19","author":"Thomas","year":"2013","journal-title":"Nature Medicine"},{"issue":"1\u20132","key":"10.1016\/bs.ai.2015.09.004_bb1230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"Journal of Immunological Methods"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb1235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","article-title":"Autoreactivity in human IgG+ memory B cells","volume":"26","author":"Tiller","year":"2007","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb1240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"issue":"49","key":"10.1016\/bs.ai.2015.09.004_bb1245","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1016\/j.vaccine.2008.09.080","article-title":"Deceptive imprinting and immune refocusing in vaccine design","volume":"26","author":"Tobin","year":"2008","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/bs.ai.2015.09.004_bb9080","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb9085","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/JVI.70.2.1100-1108.1996","article-title":"Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1","volume":"70","author":"Trkola","year":"1996","journal-title":"Journal of Virology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb1250","first-page":"1727","article-title":"VH4-34 encoded antibodies in systemic lupus erythematosus: A specific diagnostic marker that correlates with clinical disease characteristics","volume":"26","author":"van Vollenhoven","year":"1999","journal-title":"The Journal of Rheumatology"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb1255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: Implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nature Reviews. Immunology"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb1260","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"issue":"5362","key":"10.1016\/bs.ai.2015.09.004_bb9090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection","volume":"280","author":"Veazey","year":"1998","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb1265","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.4049\/jimmunol.1101633","article-title":"Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls","volume":"187","author":"Verkoczy","year":"2011","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2015.09.004_bb1270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1073\/pnas.0912914107","article-title":"Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance","volume":"107","author":"Verkoczy","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb1275","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/eji.201142313","article-title":"Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13","volume":"42","author":"Visentini","year":"2012","journal-title":"European Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1280","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.autrev.2012.08.016","article-title":"Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: The yin and yang of HCV-driven lymphoproliferation and autoimmunity","volume":"12","author":"Visentini","year":"2013","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/bs.ai.2015.09.004_bb1285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-7580-5-1","article-title":"Genetic correlates of autoreactivity and autoreactive potential in human Ig heavy chains","volume":"5","author":"Volpe","year":"2009","journal-title":"Immunome Research"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb1290","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/0959-437X(93)90008-D","article-title":"The fastest genome evolution ever described: HIV variation in situ","volume":"3","author":"Wain-Hobson","year":"1993","journal-title":"Current Opinion in Genetics and Development"},{"issue":"7","key":"10.1016\/bs.ai.2015.09.004_bb1295","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ai.2015.09.004_bb1300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-385032-4.00002-1","article-title":"Adaptive immunity to the hepatitis C virus","volume":"78","author":"Walker","year":"2010","journal-title":"Advances in Virus Research"},{"issue":"7365","key":"10.1016\/bs.ai.2015.09.004_bb1305","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"issue":"5638","key":"10.1016\/bs.ai.2015.09.004_bb1310","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.ai.2015.09.004_bb1315","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: A new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.ai.2015.09.004_bb1320","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","article-title":"A new CD21low B cell population in the peripheral blood of patients with SLE","volume":"113","author":"Wehr","year":"2004","journal-title":"Clinical Immunology"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb1325","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"Journal of Immunology"},{"issue":"6929","key":"10.1016\/bs.ai.2015.09.004_bb1330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1335","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.4049\/jimmunol.0901297","article-title":"Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area","volume":"183","author":"Weiss","year":"2009","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1340","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.immuni.2005.08.007","article-title":"Evidence of marginal-zone B cell-positive selection in spleen","volume":"23","author":"Wen","year":"2005","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/bs.ai.2015.09.004_bb1345","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2014.01.052","article-title":"Structural insights on the role of antibodies in HIV-1 vaccine and therapy","volume":"156","author":"West","year":"2014","journal-title":"Cell"},{"issue":"10","key":"10.1016\/bs.ai.2015.09.004_bb1350","doi-asserted-by":"crossref","first-page":"e1003738","DOI":"10.1371\/journal.ppat.1003738","article-title":"Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes","volume":"9","author":"Wibmer","year":"2013","journal-title":"PLoS Pathogens"},{"key":"10.1016\/bs.ai.2015.09.004_bb1355","doi-asserted-by":"crossref","first-page":"292591","DOI":"10.1155\/2012\/292591","article-title":"In vitro systems for the study of hepatitis C virus infection","volume":"2012","author":"Wilson","year":"2012","journal-title":"International Journal of Hepatology"},{"issue":"5993","key":"10.1016\/bs.ai.2015.09.004_bb1360","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"9","key":"10.1016\/bs.ai.2015.09.004_bb1365","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1128\/JVI.69.9.5723-5733.1995","article-title":"Involvement of the V1\/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding","volume":"69","author":"Wyatt","year":"1995","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.ai.2015.09.004_bb1370","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2009.09.029","article-title":"Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens","volume":"390","author":"Xiao","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"14","key":"10.1016\/bs.ai.2015.09.004_bb1375","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/JVI.00410-10","article-title":"Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian\/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques","volume":"84","author":"Xiao","year":"2010","journal-title":"Journal of Virology"},{"issue":"8","key":"10.1016\/bs.ai.2015.09.004_bb1380","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2014\/549624","article-title":"Hepatitis C drugs: The end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: A concise review","volume":"28","author":"Yau","year":"2014","journal-title":"Canadian Journal of Gastroenterology & Hepatology"},{"issue":"40","key":"10.1016\/bs.ai.2015.09.004_bb1385","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1016\/j.vaccine.2011.07.046","article-title":"Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: Differences from the human counterparts and implications for HIV-1 vaccine development","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb9095","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1128\/JVI.67.6.3345-3356.1993","article-title":"Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection","volume":"67","author":"Zhang","year":"1993","journal-title":"Journal of Virology"},{"issue":"12","key":"10.1016\/bs.ai.2015.09.004_bb1390","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/glycob\/cwh106","article-title":"Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin","volume":"14","author":"Zhang","year":"2004","journal-title":"Glycobiology"},{"issue":"20","key":"10.1016\/bs.ai.2015.09.004_bb1395","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1073\/pnas.0703039104","article-title":"Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma","volume":"104","author":"Zhang","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"26","key":"10.1016\/bs.ai.2015.09.004_bb1400","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.ai.2015.09.004_bb1405","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/IAI.72.6.3505-3514.2004","article-title":"Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B","volume":"72","author":"Zhou","year":"2004","journal-title":"Infection and Immunity"},{"key":"10.1016\/bs.ai.2015.09.004_bb1410","doi-asserted-by":"crossref","first-page":"980942","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","volume":"2012","author":"Zignego","year":"2012","journal-title":"Clinical and Developmental Immunology"},{"issue":"19","key":"10.1016\/bs.ai.2015.09.004_bb1415","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1128\/JVI.05086-11","article-title":"Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA","volume":"85","author":"Zolla-Pazner","year":"2011","journal-title":"Journal of Virology"}],"container-title":["Advances in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065277615000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065277615000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:43:09Z","timestamp":1718152989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065277615000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128047996"],"references-count":304,"URL":"https:\/\/doi.org\/10.1016\/bs.ai.2015.09.004","relation":{},"ISSN":["0065-2776"],"issn-type":[{"value":"0065-2776","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}